Executive Summary

Investment Thesis: MSOS provides targeted exposure to the US cannabis ecosystem, including REITs, ancillary services, and operators. The theme benefits from improving state-level legalization and investor rotation into beaten down names, but the fund is very volatile and sensitive to headlines and liquidity. For investors who want concentrated US cannabis exposure MSOS can be a tactical allocation, but you should treat it as speculative and size positions accordingly.

Current Price: $3.77 | Key Metric: AUM: ~$190M (est) | Stance: NEUTRAL

Company Overview

MSOS is the AdvisorShares Pure US Cannabis ETF, a thematic exchange traded fund designed to track US-listed companies tied to the domestic cannabis market. The fund targets a mix of operators, landlords, ancillary service providers, and other businesses that generate revenue from US cannabis activity.

Key Products & Competitive Position

Core Business: The ETF aggregates exposure to US cannabis related equities through a concentrated, actively managed portfolio.
Key Products: Long-only ETF share class, intraday tradability offering direct exposure to US cannabis equities.
Competitive Moat: The moat is limited; MSOS offers niche thematic access and active management, but it competes with other cannabis ETFs and direct stock positions. Liquidity and fees are the main differentiators for some investors.

Recent Developments

MSOS has seen elevated volatility in early 2026, including a sharp decline on 2/22/2026 when the share price dropped about 10% intraday. Year to date the fund is up, reflecting renewed investor interest in the cannabis theme. At the same time the underlying asset class remains sensitive to macro risk, headline risk, and state and federal policy discussions.

Financial Snapshot

Market Cap$0.19B

P/E RatioN/A

52-Week Range$2.02 - $7.25

Dividend Yield0.0%

EPS (TTM)N/A

ROEN/A

Revenue & Earnings Trends

MSOS is an ETF and does not report revenue or earnings in the conventional sense. Performance is driven by the price action of its underlying holdings, which include a mix of REITs, operators and ancillary companies. Over the prior 12 months the fund returned approximately 12.2 percent, while YTD performance is notably stronger at about 20.1 percent as investor risk appetite for the theme recovered.

Balance Sheet Highlights

As an ETF MSOS does not have an operating balance sheet. Investors should instead monitor AUM, liquidity, bid-ask spreads, and creation/redemption activity. AUM is modest versus large broad market ETFs which increases the potential for wider spreads in stressed conditions.

Valuation Analysis

Current Valuation Metrics

Forward P/EN/Avs Industry: N/A

PEG RatioN/AGrowth-adjusted

EV/EBITDAN/Avs Historical: N/A

P/S RatioN/Avs Peers: N/A

Historical Comparison

MSOS traded as high as $11.26 on some multi-year closes historically and hit a 52-week high of $7.25 in December 2025. Since then the fund has retraced significantly, finishing the most recent session at $3.77, roughly 48 percent below the 52-week high. Volatility has been large with two year total return metrics showing steep swings depending on period chosen.

Fair Value Estimate

Valuing a thematic ETF requires valuing its underlying holdings and the probability of regulatory normalization. If US federal reform meaningfully improves access to capital and banking for cannabis firms the group could rerate. On the other hand if reforms stall the sector may remain range bound or decline. A pragmatic fair value estimate for MSOS, given current volatility and the ETF's concentration, is roughly $4.00 to $5.50, depending on timing of catalysts and risk premia compression.

Competitive Landscape

Market Position

Market Share: Small share of the cannabis ETF market | Ranking: Niche thematic ETF focused on US cannabis names

Key Competitors

$YOLOAdvisorShares Pure Cannabis ETF focused on a slightly different cannabis mix including non US exposure

$CNBSOther cannabis themed ETFs and actively managed funds that target similar cohorts

Direct equity exposureInvestors often choose leading MSOs and ancillary stocks instead of a single ETF

Competitive Advantages

Moat 1: Thematic focus gives concentrated exposure to a high beta segment, useful for investors wanting targeted positioning without selecting single names.
Moat 2: Active management can shift weights to the most promising subsegments and manage liquidity through creation/redemption channels.
Moat 3: Liquidity for retail traders during normal markets, with intraday tradability and ETF convenience.

Earnings Track Record

Last 4 Quarters: Not applicable / Not applicable

Recent Earnings History

Q4 2025N/A for ETFN/A

Q3 2025N/A for ETFN/A

Q2 2025N/A for ETFN/A

Q1 2025N/A for ETFN/A

Guidance Trend

ETF managers do not issue earnings guidance. Instead watch guidance and results from MSOS top holdings, and monitor commentary on state legalization, federal policy, and banking reforms which drive sector-level expectations.

Analyst Sentiment

Consensus Rating: Hold

Strong Buy: 0 Buy: 1 Hold: 3 Sell: 0

Price Targets

Low: $3.00
Mean: $4.20 (+11.5% upside)
High: $6.00

Recent Analyst Actions

Coverage for MSOS by traditional sell side analysts is limited relative to single equity coverage. Most recent public notes focus on the broader cannabis space and large component companies rather than ETF specific changes. That means there are fewer formal price target revisions for the ETF itself and more analyst commentary at the industry level.

Recent News & Catalysts

Key Developments

2/22/2026 Intraday Selloff: MSOS fell roughly 10 percent in a single session, reflecting headline sensitivity and a rotation out of small thematic ETFs.
State-level legalization momentum: Several states continued to adjust regulations in 2025 and early 2026 which supports longer term demand for US cannabis operators and ancillary businesses.
Capital markets improvement: Some larger MSOs have gained easier access to capital in late 2025, easing near term liquidity fears and enabling M&A activity.

Upcoming Catalysts

Next Earnings: N/A for ETF | Key Events: Quarterly results and guidance from MSOS top holdings, any federal legislative developments regarding banking or de-scheduling, and state ballot initiatives this cycle.

Technical Outlook

Current Price: $3.77 vs 52-Week High: $7.25 (-48% from high)

Trend Analysis

The intermediate trend is choppy. After making a 52-week high in December 2025 the ETF has retraced and moved into a lower trading range. Momentum indicators show short term oversold readings following the recent 10 percent drop. That can attract short term buyers, yet the longer term trend is still defined by volatility and headline risk so moves can reverse quickly.

Key Levels

Resistance: $4.50, $5.50
Support: $3.20, $2.50

Bull vs Bear Case

Bull Case

Catalyst 1: Federal policy progress that improves banking and access to institutional capital, which would materially reduce risk premia for US cannabis names.
Catalyst 2: Continued state legalization and growing retail demand, bolstering revenues and margins for operators and real estate players.
Catalyst 3: Current price reflects a distressed multiple and concentrated holdings; a rotation back into growth themes could drive meaningful upside.

Bull Target: $6.50 (+72%)

Bear Case

Risk 1: Federal inaction or adverse rulings that keep banking and tax burdens in place, which would cap sector profitability and access to capital.
Risk 2: Liquidity risk and concentration risk in a small AUM ETF, which can exacerbate price declines during market stress.
Risk 3: Underperformance of large holdings, such as REITs or major operators, which would depress NAV and investor sentiment.

Bear Target: $2.50 (-34%)

Risks to Consider

Valuation Risk: Thematic ETFs can swing widely in valuation. MSOS can move from deeply discounted to richly priced quickly, exposing investors to timing risk.
Competitive Risk: Multiple cannabis ETFs and direct stock options mean flows can shift rapidly, affecting liquidity and bid ask spreads for MSOS.
Macro Risk: Rising interest rates or a broad market risk-off can pressure small cap and highly leveraged names within the fund, reducing asset values.
Execution Risk: The fund depends on manager access to liquidity and efficient creations and redemptions. Low AUM could lead to wider gaps in stressed markets.

Bottom Line

Investment Verdict: NEUTRAL

MSOS offers a straightforward way to gain concentrated exposure to the US cannabis theme, and the recent pullback could look attractive to investors who accept high volatility. However the fund remains headline sensitive and dependent on regulatory progress. You should treat MSOS as a tactical, speculative allocation rather than a core holding.

Action Items for Investors

Long-term investors: Consider a small, staged allocation and add on confirmed policy progress or sustained earnings improvements in top holdings.
Short-term traders: Trade the volatility with tight risk controls. Look for intraday mean reversion around support levels and use stop losses to limit drawdowns.
Risk management: Limit position size to a small percentage of your portfolio, diversify across themes, and avoid overexposure to a single ETF with modest AUM.

What to Watch This Week

News or legislative movement on federal cannabis policy and banking reform.
Quarterly updates and guidance from MSOS large holdings, especially REITs and major operators.
ETF flows and spreads, which signal whether retail or institutional investors are rotating into or out of the theme.

MSOS: US Cannabis ETF Outlook